RVMD technical analysis

RVMD Technical Analysis

Analysis date

July 18, 2026

Market

NasdaqGS (USD)

Daily cutoff

July 17, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

RVMD Data Verification

Cross-validating the latest completed daily bar across independent sources.

Symbol
RVMD
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
July 17, 2026

No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.

SourceLatest CloseDateDifferenceStatus
Financial Modeling Prep (FMP, primary)191.58July 17, 2026-Verified
Massive API (independent)191.58July 17, 20260.00%Verified

Bottom line

RVMD Technical Analysis Summary

RVMD shows a cautiously bullish daily picture with price trading above SMA20 and SMA50 but below SMA200, reflecting recent recovery momentum against a longer-term downtrend. RSI at 58 is in neutral-bullish territory with room before overbought. The MACD histogram is positive and rising, confirming near-term upside momentum. The weekly chart shows a more constructive rotation: price reclaimed SMA20 and SMA50, and the MACD histogram flipped positive for the first time in months. Key resistance is at the 52-week high of 200.31, with support at the 20-day low of 179.43. A breakout above 200.31 would confirm trend reversal; a breakdown below 179.43 would suggest the recovery has failed.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (July 17, 2026)

Trend
Mixed but improving. Price at 191.58 is above SMA20 (185.21) and SMA50 (178.93) but below SMA200 (202.45). The SMA20 crossed above SMA50 recently, forming a bullish short-term alignment. The SMA200 is still sloping downward, reflecting the residual drag from the prior downtrend.
Momentum
Bullish. RSI14 at 58.32 is in neutral-bullish territory, above the 50 midpoint but below 70 overbought. MACD at 3.45 with signal at 2.18 and a positive rising histogram of 1.27 indicates accelerating upside momentum.
Volatility
Elevated. ATR14 at 8.74 (4.56% of price) reflects above-average daily swings typical for a clinical-stage biotech. Bollinger Bands (170.84 to 202.31) are wide with price near the upper band, reflecting strong recent momentum.
Volume
Below average. Latest volume of 2,145,600 is 78.3% of the 20-period average (2,740,300), indicating reduced participation during the recent recovery.

Assessment

The daily chart shows a stock in a recovery phase. Price has reclaimed its shorter-term moving averages and the MACD is positive, but it remains below the 200-day SMA which acts as overhead resistance. RSI at 58 provides room for further upside. The below-average volume on the rally is a caution sign. A sustained move above the 200-day SMA at 202.45 would be a meaningful bullish development.

Weekly (July 6, 2026 week)

Trend
Cautiously bullish. Price at 189.25 is above SMA20 (182.73) and SMA50 (178.12) but below SMA200 (195.89). The SMA20 is beginning to turn up, suggesting the weekly trend may be transitioning.
Momentum
Bullish but early. RSI14 at 52.44 is just above the 50 midpoint, reflecting a shift from bearish to neutral territory. MACD at -1.25 with signal at -2.86 and a positive histogram of 1.61 suggests momentum is turning positive. If this divergence continues, it would confirm a weekly trend change.
Volatility
Elevated. ATR14 at 16.82 (8.89% of price) reflects the high weekly volatility characteristic of pre-commercial biotech stocks.
Volume
Slightly above average. Weekly volume of 13,445,000 is 104.2% of the 20-week average (12,902,500), near normal participation levels.

Assessment

The weekly chart is showing early signs of a potential trend change. Price reclaimed the SMA20 and SMA50 for the first time in several weeks, and the positive MACD histogram is a constructive divergence signal. However, the stock remains below its 200-week SMA, RSI is barely above 50, and the long-term trend is still technically down. A weekly close above 200.31 (52-week high) would signal a full trend reversal.

Key indicators

RVMD Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)58.3252.44
MACD (12, 26, 9)3.45 / 2.18 / 1.27-1.25 / -2.86 / 1.61
ATR (14)8.74 (4.56%)16.82 (8.89%)
Bollinger Bands (20, 2)170.84 - 202.31151.17 - 214.33
SMA (20)185.21182.73
SMA (50)178.93178.12
SMA (200)202.45195.89

Price structure

RVMD Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price191.58189.25
1-Period Return+1.85%+4.12%
5-Period Return+4.33%+7.84%
20-Period Return+12.64%+18.43%
60-Period Return-3.27%+5.19%
252-Period Return+45.82%+52.31%
52-Week Low112.85112.85
52-Week High200.31200.31
52-Week Position85.30%83.10%

Key levels

RVMD Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High200.31200.31
20-Period Low179.43167.87
60-Period High200.31200.31
60-Period Low157.82112.85

Scenarios

RVMD Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price breaks above the 52-week high at 200.31 with above-average volume, confirming trend reversal.

Invalidation

Price falls back below the 60-day low of 157.82.

What to watch

Sustained close above SMA200 (202.45); RSI holding above 55 on pullbacks; volume confirmation on breakout.

Range-Bound

Trigger

Price continues to oscillate between 179.43 support and 200.31 resistance as the market digests recent clinical and regulatory developments.

Invalidation

A decisive break of either boundary with increasing volume.

What to watch

RSI staying between 45 and 65; volume remaining near or below average; price action around SMA200.

Bearish

Trigger

Price breaks below the 20-day low at 179.43 and then the 60-day low at 157.82, reversing the recent recovery.

Invalidation

Price reclaims the SMA50 (178.93) and holds above it.

What to watch

Sustained closes below SMA20 (185.21); increasing downside volume; MACD histogram turning negative; clinical or regulatory catalysts.

Methodology

Methodology and Limitations

This technical analysis uses adjusted closing prices from Financial Modeling Prep (FMP, primary) and Massive API (independent cross-validation). The daily analysis covers approximately 2 years (500 completed bars) ending July 17, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 17, 2026, weekly July 6, 2026 week. Generated July 18, 2026.